HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
25 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
TCOF1
treacle ribosome biogenesis factor 1
Chromosome 5 Β· 5q32-q33.1
NCBI Gene: 6949Ensembl: ENSG00000070814.22HGNC: HGNC:11654UniProt: B4DRA2
246PubMed Papers
21Diseases
0Drugs
230Pathogenic Variants
FUNCTIONAL ROLE
Highly Constrained
RESEARCH IMPACT
TrendingVariant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
RNA bindingprotein bindingprotein-macromolecule adaptor activityprotein heterodimerization activityTreacher Collins syndrome 1Treacher-Collins syndromegenetic disorderneurodegenerative disease
✦AI Summary

TCOF1 encodes treacle, a nucleolar protein that serves as a central regulator of ribosome biogenesis and RNA polymerase I activity 1. The protein acts as a scaffold, connecting RNA polymerase I with enzymes responsible for ribosomal processing and modification, thereby regulating ribosomal DNA transcription and pre-ribosomal RNA processing 2. TCOF1 is essential for neural crest development, where following monoubiquitination, it associates with NOLC1 to remodel the translational program favoring neural crest specification 1. Loss-of-function mutations in TCOF1 cause Treacher Collins syndrome, an autosomal dominant craniofacial disorder affecting 1 in 50,000 births, characterized by abnormal development of pharyngeal arches leading to microtia, hearing loss, and midface hypoplasia 34. Haploinsufficiency results in neural crest cell depletion through increased cell death in the neuroepithelium 4. Beyond developmental roles, TCOF1 has oncogenic functions in hepatocellular carcinoma, coordinating KRAS activation and rRNA production while affecting immune cell infiltration 5. The protein also maintains mitochondrial homeostasis through FLVCR1-mediated pathways and has been implicated in cellular senescence prevention 67. Variants in TCOF1 have also been associated with human neural tube defects 8.

Sources cited
1
TCOF1 is a nucleolar protein that regulates ribosome biogenesis and multiple cellular processes
PMID: 33804586
2
TCOF1 interacts with RNA polymerase I and facilitates pre-rRNA transcription
PMID: 40067889
3
TCOF1 mutations cause Treacher Collins syndrome affecting 1 in 50,000 births
PMID: 34573374
4
Haploinsufficiency causes neural crest cell depletion through increased cell death
PMID: 17552945
5
TCOF1 has oncogenic roles in hepatocellular carcinoma
PMID: 34904330
6
TCOF1 maintains mitochondrial homeostasis through FLVCR1-mediated pathways
PMID: 39237990
7
TCOF1 binding maintains ribosome homeostasis and alleviates cellular senescence
PMID: 40128218
8
TCOF1 variants are associated with human neural tube defects
PMID: 36808708
Disease Associationsβ“˜21
Treacher Collins syndrome 1Open Targets
0.76Strong
Treacher-Collins syndromeOpen Targets
0.63Moderate
genetic disorderOpen Targets
0.47Moderate
neurodegenerative diseaseOpen Targets
0.46Moderate
alopecia areataOpen Targets
0.28Weak
Emery-Dreifuss muscular dystrophy 4, autosomal dominantOpen Targets
0.27Weak
lysosomal storage diseaseOpen Targets
0.23Weak
Hearing impairmentOpen Targets
0.12Weak
microcephalyOpen Targets
0.12Weak
triple-negative breast cancerOpen Targets
0.09Suggestive
cancerOpen Targets
0.09Suggestive
hepatocellular carcinomaOpen Targets
0.09Suggestive
neural tube defects, folate-sensitiveOpen Targets
0.07Suggestive
Isolated anencephaly/exencephalyOpen Targets
0.07Suggestive
anencephaly 1Open Targets
0.07Suggestive
neoplasmOpen Targets
0.06Suggestive
holoprosencephalyOpen Targets
0.06Suggestive
Spina bifida - hypospadiasOpen Targets
0.05Suggestive
spina bifida-hypospadias syndromeOpen Targets
0.05Suggestive
X-linked dominant chondrodysplasia, Chassaing-Lacombe typeOpen Targets
0.05Suggestive
Treacher Collins syndrome 1UniProt
Pathogenic Variants230
NM_001371623.1(TCOF1):c.2796_2797del (p.Gly933fs)Pathogenic
Treacher Collins syndrome 1|not provided
β˜…β˜…β˜†β˜†2026β†’ Residue 933
NM_001371623.1(TCOF1):c.1448_1451del (p.Asp483fs)Pathogenic
not provided|Treacher Collins syndrome 1
β˜…β˜…β˜†β˜†2025β†’ Residue 483
NM_001371623.1(TCOF1):c.4372_4376del (p.Lys1458fs)Pathogenic
Treacher Collins syndrome 1|not provided|Treacher Collins syndrome|Inborn genetic diseases
β˜…β˜…β˜†β˜†2025β†’ Residue 1458
NM_001371623.1(TCOF1):c.2103_2106del (p.Ser701fs)Pathogenic
Treacher Collins syndrome 1|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 701
NM_001371623.1(TCOF1):c.2962C>T (p.Arg988Ter)Pathogenic
Treacher Collins syndrome 1|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 988
NM_001371623.1(TCOF1):c.1021_1022del (p.Ser341fs)Pathogenic
Treacher Collins syndrome 1|Treacher Collins syndrome|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 341
NM_001371623.1(TCOF1):c.1978C>T (p.Arg660Ter)Pathogenic
not provided|Treacher Collins syndrome 1
β˜…β˜…β˜†β˜†2025β†’ Residue 660
NM_001371623.1(TCOF1):c.4029G>A (p.Trp1343Ter)Pathogenic
Treacher Collins syndrome 1|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 1343
NM_001371623.1(TCOF1):c.2285_2286del (p.Asp761_Ser762insTer)Pathogenic
Treacher Collins syndrome 1|not provided
β˜…β˜…β˜†β˜†2024β†’ Residue 761
NM_001371623.1(TCOF1):c.2112_2116del (p.Glu704fs)Pathogenic
Treacher Collins syndrome 1|TCOF1-related disorder
β˜…β˜…β˜†β˜†2024β†’ Residue 704
NM_001371623.1(TCOF1):c.4342_4343del (p.Lys1448fs)Pathogenic
Treacher Collins syndrome 1|not provided
β˜…β˜…β˜†β˜†2024β†’ Residue 1448
NM_001371623.1(TCOF1):c.1016C>G (p.Ser339Ter)Pathogenic
not provided|Treacher Collins syndrome 1
β˜…β˜…β˜†β˜†2024β†’ Residue 339
NM_001371623.1(TCOF1):c.4358_4359del (p.Lys1453fs)Pathogenic
not provided|Treacher Collins syndrome 1
β˜…β˜…β˜†β˜†2024β†’ Residue 1453
NM_001371623.1(TCOF1):c.1017dup (p.Glu340fs)Pathogenic
not provided|Treacher Collins syndrome 1
β˜…β˜…β˜†β˜†2023β†’ Residue 340
NM_001371623.1(TCOF1):c.3490C>T (p.Gln1164Ter)Pathogenic
Treacher Collins syndrome 1
β˜…β˜…β˜†β˜†2023β†’ Residue 1164
NM_001371623.1(TCOF1):c.4221dup (p.Ser1408fs)Pathogenic
Treacher Collins syndrome 1|not provided
β˜…β˜…β˜†β˜†2023β†’ Residue 1408
NM_001371623.1(TCOF1):c.862C>T (p.Arg288Ter)Pathogenic
not provided|Treacher Collins syndrome 1
β˜…β˜…β˜†β˜†2023β†’ Residue 288
NM_001371623.1(TCOF1):c.1639_1640del (p.Ser547fs)Pathogenic
Treacher Collins syndrome 1|TCOF1-related disorder
β˜…β˜…β˜†β˜†2023β†’ Residue 547
NM_001371623.1(TCOF1):c.3388del (p.Leu1130fs)Likely pathogenic
Treacher Collins syndrome 1
β˜…β˜…β˜†β˜†2023β†’ Residue 1130
NM_001371623.1(TCOF1):c.4369_4372del (p.Glu1457fs)Pathogenic
Treacher Collins syndrome 1
β˜…β˜…β˜†β˜†2023β†’ Residue 1457
View on ClinVar β†—
Related Genes
POLR1DProtein interaction100%UBTFProtein interaction96%NOP56Protein interaction92%LNX2Protein interaction91%NOLC1Protein interaction80%OFD1Protein interaction78%
Tissue Expression6 tissues
Bone Marrow
100%
Ovary
89%
Lung
82%
Brain
66%
Heart
60%
Liver
50%
Gene Interaction Network
Click a node to explore
TCOF1POLR1DUBTFNOP56LNX2NOLC1OFD1
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted Β· UniProt Q13428
View on AlphaFold β†—
Constraintβ“˜
LOEUFβ“˜
0.29Highly Constrained
pLIβ“˜
1.00Intolerant
Observed/Expected LoF0.22 [0.16–0.29]
RankingsWhere TCOF1 stands among ~20K protein-coding genes
  • #1,581of 20,598
    Most Researched246 Β· top 10%
  • #280of 5,498
    Most Pathogenic Variants230 Β· top 10%
  • #1,045of 17,882
    Most Constrained (LOEUF)0.29 Β· top 10%
Genes detectedTCOF1
Sources retrieved25 papers
Response timeβ€”
πŸ“„ Sources
25β–Ό
1
Treacher Collins Syndrome: Genetics, Clinical Features and Management.
PMID: 34573374
Genes (Basel) Β· 2021
1.00
2
High-content screening identifies ganoderic acid A as a senotherapeutic to prevent cellular senescence and extend healthspan in preclinical models.
PMID: 40128218
Nat Commun Β· 2025
0.90
3
The Role of
PMID: 33804586
Int J Mol Sci Β· 2021
0.80
4
TCOF1 coordinates oncogenic activation and rRNA production and promotes tumorigenesis in HCC.
PMID: 34904330
Cancer Sci Β· 2022
0.70
5
NBS1 facilitates preribosomal RNA biogenesis.
PMID: 40067889
Proc Natl Acad Sci U S A Β· 2025
0.60